Nitric oxide synthase isozymes characterization, purification, molecular cloning, and functions

Hypertension

Volumn 23, Issue 6, 1994, Pages 1121-1131

  Förstermann, Ulrich ^a   Closs, Ellen I ^a   Pollock, Jennifer S ^b   Nakane, Masaki ^b   Schwarz, Petra ^a   Gath, Ingo ^a   Kleinert, Hartmut ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Blood pressure; Brain; Endothelial cells; Endothelium derived relaxing factor; Induced macrophages; L arginine; Nitrergic nerves; Septic shock

Indexed keywords

ISOENZYME; NITRIC OXIDE SYNTHASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME BINDING; ENZYME PURIFICATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

AMINO ACID OXIDOREDUCTASES; ANIMALS; ARGININE; CLONING, MOLECULAR; HUMANS; ISOENZYMES; NITRIC OXIDE SYNTHASE; TISSUE DISTRIBUTION;

EID: 0028332056     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.23.6.1121     Document Type: Article

References (177)

1. Green LC, Tannenbaum SR, Goldmann P. Nitrate synthesis in the germfree and conventional rat. Science. 1981;212:56–58.
2. Stuehr DJ, Marietta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA. 1985;82: 7738–7742.
3. lyengar R, Stuehr DJ, Marietta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Set USA. 1987;84:6369–6373.
4. Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role of L-argininc deiminasc and imino nitrogen oxidation to nitrite. Science. 1987;235:473–476.
5. Marietta MA, Yoon PS, lyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706–8711.
6. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.
7. Furchgott RF, Cherry PD, Zawadzki JV, Jothianandan D. Endothelial cells as mediators of vasodilation of arteries. J Cardwvasc Pharmacol. 1984;3:557–573.
8. Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ. Association between cyclic GMP accumulation and acetylcholineelicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther. 1984;228:682–690.
9. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 1983,52:352–357.
10. Fiscus RR, Rapoport RM, Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cyclic Nucleotide Protein Phosphor Res. 1983;9:415–425.
11. F6rstermann U, Mulsch A, Bohme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium- derived factor from rabbit and canine arteries. Circ Res. 1986; 58:531–538.
12. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986;237:893–900.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;27:524–526.
14. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P, ed. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium. New York, NY: Raven Press, Publishers; 1988:401–414.
15. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-denved relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84: 9265–9269.
16. Schmidt HHHW, Nau H, Wittfoht W, Gerlach J, Prescher KE, Klein MM, Niroomand F, Bohme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 1988;154:213–216.
17. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333: 664–666.
18. Knowles RG, Palacios M, Palmer RM, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Nad Acad Sci US A. 1989;86:5159–5162.
19. Forstermann U, Gorsky LD, Pollock JS, Ishii K, Schmidt HH, Heller M, Murad F. Hormone-induced biosynthesis of endothelium- derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol. 1990;8:7–13.
20. Garthwaite J, Charles SL, Chess-Williams R. Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385–388.
21. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Nad Acad Set USA. 1990;87: 682–685.
22. Schmidt HHHW, Pollock JS, Nakane M, Gorsky LD, Forstermann U, Murad F. Purification of a soluble isoform of guanyh/l cyclase-activating-factor synthase. Proc Natl Acad Sci USA. 1991;88:365–369.
23. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA. 1991;88:7773–7777.
24. Hevel JM, White KA, Marietta MA. Purification of the inducible murine macrophage nitric oxide synthase: identification as a flavoprotein. J Biol Chem. 1991;266:22789–22791.
25. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Kawai C. Purification of nitric oxide synthase from rat macrophages. J Biol Chem. 1991;266:12544–12547.
26. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HHHW, Nakane M, Murad F. Purification and characterization of paniculate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 1991;88:10480–10484.
27. Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Bohme E. Brain nitric oxide synthase is a biopterin- and flavincontaining multi-functional oxido-reductase. FEBS Lett. 1991; 288:187–191.
28. Hevel JM, Marietta MA. Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity. Biochemistry. 1992;31:7160–7165.
29. Pollock JS, Werner ER, Mitchell JA, Forstermann U. Paniculate endothelial nitric oxide synthase: requirement and content of tetrahydrobiopterin, FAD and FMN. Endothelium. 1993;1: 147–152.
30. McMillan K, Bredt DS, Hirsch DJ, Snyder SH, Clark JE, Masters BS. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci USA. 1992;89:11141–11145.
31. White KA, Marietta MA. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry. 1992;31:6627–6631.
32. Mayer B, John M, Bohme E. Purification of a calcium/calmodulindependent nitric oxide synthase from porcine cerebellum: cofactor role of tetrahydrobiopterin. FEBS Lett. 1990;277:215–219.
33. Hiki K, Hattori R, Kawai C, Yui Y. Purification of insoluble nitric oxide synthase from rat cerebellum. J Biochem (Tokyo). 1992;111: 556–558.
34. Matsumoto T, Pollock JS, Nakane M, Forstermann U. Developmental changes of cytosolic and paniculate nitric oxide synthase in rat brain. Dev Brain Res. 1993;73:199–203.
35. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351: 714–718.
36. Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 1993;316:175–180.
37. Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478–17488.
38. Xu WM, Gorman P, Sheer D, Bates G, Kishimoto J, Lizhi L, Emson P. Regional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q24.2–24.31 by fluorescent in situ hybridization. Cytogenet Cell Genet. 1993;64:62–63.
39. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225–228.
40. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem. 1992;267:6370–6374.
41. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA. 1992;89:6711–6715.
42. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;191:89–94.
43. Wood ER, Berger HJ, Sherman PA, Lapetina EG. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem Biophys Res Commun. 1993; 191: 767–774.
44. Adachi H, lida S, Oguchi S, Ohshima H, Suzuki H, Nagasaki K, Kawasaki H, Sugimura T, Esumi H. Molecular cloning of a cDNA encoding an inducible calmodulin-dependent nitric-oxide synthase from rat liver and its expression in COS-1 cells. Eur J Biochem. 1993;217:37–43.
45. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di SM, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA. 1993;90:3491–3495.
46. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc NatlAcad Sci USA. 1993;90: 11419–11423.
47. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry. 1993;32:11600–11605.
48. Xu W, Charles I, Moncada S, Gorman P, Liu L, Emson P. Chromosomal assignment of the inducible NOS gene and endothelial NOS gene to human chromosome 17pl l-17ql 1 and chromosome 7, respectively. Endothelium (Suppl). 1993; 1:S24. Abstract.
49. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D’Angelo DD, Lynch KR, Peach MJ. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 1992;267:15274–15276.
50. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 1992;89:6348–6352.
51. Nishida K, Harrison DG, Navas JP, Fisher A A, Dockery SP, Uematsu M, Ncrem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992;90: 2092–2096.
52. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium- derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992;267:14519–14522 (published erratum in J Biol Chem. 1992; 267:22694).
53. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992;307:287–293.
54. Forstermann U, Schmidt HHHW, Kohlhaas KL, Murad F. Induced RAW 264.7 macrophages express soluble and paniculate nitric oxide synthase: inhibition by transforming growth factor-beta. Eur J Pharmacol. 1992;225:161–165.
55. Klinghofer V, Barlow J, Pollock JS, Forstermann U, Tracey WR. Immunochemical evidence that identical proteins arc responsible for soluble and paniculate nitric oxide synthase activity in induced macrophages. FASEB J. 1993;7:A258. Abstract.
56. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by intcrferon-gamma and lipopolysaccharide. Proc Natl Acad Sci USA. 1993;90: 9730–9734.
57. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 1993;177:1779–1784.
58. Forstermann U, Pollock JS, Schmidt HH, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the paniculate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci US A. 1991;88:1788–1792.
59. Pollock JS, Klinghofer V, Forstermann U, Murad F. Endothelial nitric oxide synthase is myristylated. FEBS Leu. 1992;309: 402–404.
60. Sessa WC, Barber CM, Lynch KR. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Ore Res. 1993;72:921–924.
61. Robinson LJ, Michel T. Chromosomal localization and genomic organization of the human constitutive endothelial nitric oxide synthase gene. Endothelium (Suppl). 1993;1:S25. Abstract.
62. Schmidt HHHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem. 1992; 40:1439–1456.
63. Dun NL, Dun SL, Forstermann U, Tseng LF. Nitric oxide synthase immunoreactivity in rat spinal cord. Neurosci Lett. 1992; 147:217–220.
64. Dun NJ, Dun SL, Wu SY, Forstermann U. Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neurosci Lett. 1993;158:51–54.
65. Sheng H, Gagne GD, Matsumoto T, Miller MF, Forstermann U, Murad F. Nitric oxide synthase in bovine superior cervical ganglion. J Neurochem. 1993;61:1120–1126.
66. Sheng H, Schmidt HH, Nakane M, Mitchell JA, Pollock JS, Forstermann U, Murad F. Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles. Br J Pharmacol. 1992;106: 768–773.
67. Saffrey MJ, Hassall CJ, Hoylc CH, Belai A, Moss J, Schmidt HH, Forstermann U, Murad F, Burnstock G. Colocalization of nitric oxide synthase and NADPH-diaphorasc in cultured myenteric neurones. Neumreport. 1992;3:333–336.
68. Hassall CJ, Saffrey MJ, Bclai A, Hoyle CH, Moules EW, Moss J, Schmidt HH, Murad F, Forstermann U, Burnstock G. Nitric oxide synthase immunoreactivity and NADPH-diaphorasc activity in a subpopulation of intrinsic neurones of the guinea-pig heart. Neurosci Lett. 1992; 143:65–68.
69. Schmidt HH, Warner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science. 1992;255:721–723.
70. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Nalt Acad Sci USA. 1991;88:2811–2814.
71. Tracey WR, Nakane M, Pollock JS, Forstermann U. Nitric oxide synthascs in neuronal cells, macrophages and endothelium are NADPH diaphorascs, but represent only a fraction of total cellular NADPH diaphorase activity. Biochem Biophys Res Commun. 1993; 195:1035–1040.
72. Matsumoto T, Nakane M, Pollock JS, Kuk JE, Forstermann U. A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Leu. 1993; 155:61–64.
73. Kleemann R, Rothe II, Kolb-Bachofcn V, Xic QW, Nathan C, Martin S, Kolb H. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 1993;328:9–12.
74. Bandalctova T, Brouct I, Bartsch H, Sugimura T, Esumi H, Ohshima H. Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with propionibacterium-aencs and lipopolysaccharide. Apmis. 1993; 101:330–336.
75. Buttery LDK, Springall DR, Carpenter A, Riveros-Moreno V, Moncada S, Cohen J, Polak JM. Distinct localization of inducible nitric oxide synthase in endotoxin-treated rats. Endothelium (Suppl). 1993;1:S27. Abstract.
76. Kobzik L, Bredt DS, Lowenstcin CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993;9:371–377.
77. Pollock JS, Nakane M, Buttery LK, Martinez A, Springall D, Polak JM, FSrstermann U, Murad F. Characterization and localization of cndothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol. 1993;265:C1379–C1387.
78. Myatt L, Brockman DE, Eis A, Pollock JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta. 1993; 14:487–495.
79. Tracey WR, Pollock JS, Murad F, Nakane M, Forstermann U. Identification of a type III (endothelial-like) paniculate nitric oxide synthase in LLC-PK1 kidney tubular epithelial cells. Am J Physiol. 1994;266:C22–C28.
80. Nakane M, Mitchell J, Forstermann U, Murad F. Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun. 1991; 180:1396–1402.
81. Brcdt DS, Ferris CD, Snydcr SH. Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Client. 1992; 267:10976–10981.
82. Dawson TM, Steiner SP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA. 1993;90:9808–9812.
83. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med. 1992; 176:599–604.
84. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium- derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res. 1992;70:123–130.
85. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci US A. 1993;90:6252–6256.
86. Corson MA, Berk BC, Navas JP, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to shear stress. Circulation. 1993;88(suppl):1-183. Abstract.
87. Forstermann U, Kuk JE, Nakane M, Pollock JS. The expression of endothelial nitric oxide synthase is downregulated by tumor necrosis factor (TNF-alpha). Naunyn Schmiedebergs Arch Pharmacol. 1993;347(suppl):R61. Abstract.
88. Suschek C, Rothe H, Fehsel K, Enczmann J, Kolb-Bachofen V. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells: IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J Immunol. 1993;151: 3283–3291.
89. Yoshizumi M, Perrella MA, Burnett JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase messenger RNA by shortening its half-life. Circ Res. 1993;73:205–209.
90. Bohme GA, Bon C, Stutzmann JM, Doble A, Blanchard JC. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol. 1991; 199:379–381.
91. O’Dell TJ, Hawkins RD, Kandel ER, Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A. 1991;88:11285–11289.
92. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 1991; 254:1503–1506.
93. Izumi Y, Clifford DB, Zorumski CF. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science. 1992;257:1273–1276.
94. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 1991; 349:326–328.
95. Holscher C, Rose SP. An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett. 1992;145: 165–167.
96. Chapman PF, Atkins CM, Allen MT, Haley JE, Steinmetz JE. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neumreport. 1992;3:567–570.
97. Holscher C, Rose S. Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res. 1993;619:189–194.
98. Böhme GA, Bon C, Lemaire M, Reibaud M, Piot O, Stutzmann JM, Doble A, Blanchard JC. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci USA. 1993;90:9191–9194.
99. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther. 1992;262:343–347.
100. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross SS, Levi R. NG-methyl-Larginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992;70:607–611.
101. Elkarib AO, Sheng JJ, Betz AL, Malvin RL. The central effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine) on blood pressure and plasma renin. Clin Exp Hypertens. 1993;15: 819–832.
102. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory nonadrenergic non-cholinergic neurotransmitter. Nature. 1990;345: 346–347.
103. Li CG, Rand MJ. Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol. 1991;102:91–94.
104. De Man JG, Pelckmans PA, Boeckxstaens GE, Bult H, Oosterbosch L, Herman AG, Van Maercke YM. The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol. 1991; 103:1092–1096.
105. Toda N, Okamura T. Role of nitric oxide in neurally induced cerebroarterial relaxation. J Pharmacol Exp Ther. 1991;258: 1027–1032.
106. Toda N, Okamura T. Reciprocal regulation by putatively nitroxidergic and adrenergic nerves of monkey and dog temporal arterial tone. Am J Physiol. 1991;261:H1740–H1745.
107. Cederqvist B, Wiklund NP, Persson MG, Gustafsson LE. Modulation of neuroeffector transmission in the guinea pig pulmonary artery by endogenous nitric oxide. Neurosci Lett. 1991;127:67–69.
108. Liu SF, Crawley DE, Rohde JA, Evans TW, Barnes PJ. Role of nitric oxide and guanosine 3’,5’-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol. 1992;107:861–866.
109. Toda N, Okamura T. Mechanism of neurally induced monkey mesenteric artery relaxation and contraction. Hypertension. 1992; 19:161–166.
110. Chen FY, Lee TJ. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J Pharmacol Exp Ther. 1993;265: 339–345.
111. Yoshida K, Okamura T, Kimura H, Bredt DS, Snyder SH, Toda N. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res. 1993;629:67–72.
112. Suzuki N, Fukuuchi Y, Koto A, Naganuma Y, Isozumi K, Matsuoka S, Gotoh J, Shimizu T. Cerebrovascular NADPH diaphorase-containing nerve fibers in the rat. Neurosci Lett. 1993;151:1–3.
113. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. CurrOpin Immunol. 1991;3:65–70.
114. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS, Keefer JK. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 1991;254:1001–1003.
115. Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes. 1993;42:496–500.
116. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993; 150:5080–5085.
117. Sarih M, Souvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun. 1993;191:503–508.
118. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMPdependent protein phosphorylation. Nature. 1983;306:174–176.
119. Halbriigge T, Liitsch K, Thyen A, Graefe KH. Role of nitric oxide formation in the regulation of haemodynamics and the release of noradrenaline and adrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:720–727.
120. Aisaka K, Gross SS, Griffith OW, Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun. 1989; 160: 881–886.
121. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375–3378.
122. Gardiner SM, Compton AM, Bennett T, Palmer RM, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990;15:486–492.
123. Klabunde RE, Ritger RC. N°-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun. 1991;178:1135–1140.
124. Tresham JJ, Dusting GJ, Coghlan JP, Whitworth JA. Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin Exp Pharmacol Physiol. 1991; 18:327–330.
125. Richard V, Berdeaux A, la Rochelle CD, Giudicelli JF. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs. BrJ Pharmacol. 1991; 104:59–64.
126. Persson MG, Wiklund NP, Gustafsson LE. Nitric oxide requirement for vasomotor nerve-induced vasodilatation and modulation of resting blood flow in muscle microcirculation. Ada Physiol Scantl. 1991;141:49–56.
127. Mügge A, Lopez JA, Piegors DJ, Breese KR, Heistad DD. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am J Physiol. 1991;260: H242–H247.
128. Alheid U, Frolich JC, Forstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res. 1987;47:561–571.
129. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun. 1987;148:1482–1489.
130. Radomski MW, Palmer RM, Moncada S. The anti-aggrcgating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. BrJ Pharmacol. 1987;92:639–646.
131. Bussc R, Luckhoff A, Bassenge E. Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch Pharmacol. 1987;336:566–571.
132. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc NatlAcad Sci USA. 1991; 88:4651–4655.
133. Arndt H, Smith CW, Granger DN. Lcukocyte-cndothelial cell adhesion in spontaneously hypertensive and normotensive rats. Hypertension. 1993;21:667–673.
134. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777.
135. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. EurJ Pharmacol. !990; 189:347–353.
136. Nunokawa Y, Tanaka S. lnterfcron-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun. 1992; 188:409–415.
137. Hogan M, Cerami A, Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide: role in the vascular and renal complications of diabetes mellitus. J Clin Invest. 1992;90:1110–1115.
138. Southgate K, Newby AC. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis. 1990;82: 113–123.
139. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991; 14:60–67.
140. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotouicity in primary cortical cultures. Proc NatlAcad Sci USA. 1991;88:6368–6371.
141. Nowicki JP, Duval D, Poignet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. EurJ Pharmacol. 1991;204:339–340.
142. Lefer AM, Lcfer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 1993;33:71–90.
143. Tottrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower csophagcal sphincter. Am J Physiol. 1991;260:G385–G389.
144. Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngencic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun. 1991;175:752–758.
145. Li LM, Kilbourn RG, Adams J, Fidler U. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res. 1991:51:2531–2535.
146. Green SJ, Mellouk S, Hoffman SL, Meltzer MS, Nacy CA. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induccd synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytcs. Immunol Lett. 1990;25:15–19.
147. Mulligan MS, Hevel JM, Marietta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Nail Acad Sci USA. 1991;88:6338–6342.
148. Langrehr JM, Hoffman RA, Billiar TR, Lee KK, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery. 1991;110: 335–342.
149. Bussc R, Miilsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87–90.
150. Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. Reversal of endotoxin-mediated shock by NG-methyl-L-argininc, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun. 1990;172:1132–1138.
151. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991:338:1557–1558.
152. Hibbs JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlovc RL, McMurry MP, Kushner JP, Samlowski WE. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992;89:867–877.
153. Minor RJ, Myers PR, Gucrra RJ, Bates JN, Harrison DG. Dietinduced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109–2116.
154. Fdrstermann U, Mugge A, Alherd U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Ore Res. 1988;62: 185–190.
155. Ludmer PL, Sehvyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstnetion induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046–1051.
156. Mugge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J PhysioL 1991;260: C219–C225.
157. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69: 1293–1300.
158. Sundell CL, Marsden PA, Subramanian RR, Pollock JS, Harrison DG, Wilcox JN. Nitric oxide synthase is expressed by endothelial cells overlying human atherosclerotic plaques. Circulation. 1992; 86(suppl):1-143. Abstract.
159. Luscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med. 1993;44: 395–418.
160. White MF. The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim Biophys Ada. 1985;822:355–374.
161. Kim JW, Closs El, Albritton LM, Cunningham JM. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature. 1991;352:725–728.
162. Closs EI, Lyons CR, Kelly C, Cunningham JM. Characterization of the third member of the MCAT family of cationic amino acid transporters: identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem. 1993; 268:20796–20800.
163. Drapier JC, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells in L-arginine dependent inhibition of mitochondrial iron-sulfphur enzymes in the macrophage effector cells. J Immunol 1988;140:2829–2838.
164. Takema M, Inaba K, Uno K, Kakihara KI, Tawara K, Muramatsu S. Effect of L-arginine on the retention of macrophage tumoricidal activity. J Immunol 1991;146:1928–1933.
165. Assreuy J, Moncada S. A perfusion system for the long term study of macrophage activation. Br J Pharmacol. 1992;107:317–321.
166. Bogle RG, Baydoun AR, Moncada S, Pearson JD, Mann GE. L-arginine transport is increased in macrophages generating nitric oxide. Biochem J. 1992;284:15–18.
167. Sato H, Ishii T, Sugita Y, Bannai S. Induction of cationic amino acid transport activity in mouse peritoneal macrophage by lipoporysaccharide. Biochim Biophys Ada. 1991;100:46–52.
168. Pacitti AJ, Copeland EM, Souba WW. Stimulation of hepatocyte system y+-mediated L-arginine transport by an inflammatory agent. Surgery. 1992;112:403–411.
169. Baydoun AR, Emery PW, Pearson JD, Mann GE. Substratedependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem Biophys Res Commun, 1990;173:940–948.
170. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun. 1989;164:714–721.
171. Hecker M, Mitchell JA, Harris HJ, Katsura M, Thiemermann C, Vane JR. Endothelial cells metabolize N°-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun. 1990;167:1037–1043.
172. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits, die Res. 1990;67:1301–1308.
173. Rossitch E, Alexander E, Black PM, Cooke JP. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Chn Invest 1991;87:1295–1299.
174. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;38:1546–1550.
175. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90: 1248–1253.
176. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L-arginine nitric oxide pathway in hypertension. J Hypertens. 1993;11:639–645.
177. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension. 1992;20: 511–517.